Director Ronda E. Stryker filed a Form 4 with the SEC on November 20, 2026, disclosing the exercise of a stock option and resulting changes in beneficial ownership of Stryker Corp (NYSE:SYK) common stock dated November 19, 2026.
Key Highlights
- Transaction type: Ronda E. Stryker exercised a stock option (transaction code M) on November 19, 2026, acquiring 3,605 shares of common stock.
- Exercise price: The option was exercised at $122.51 per share.
- Direct ownership following transaction: 4,367 shares held directly after the reported transaction.
- Indirect holdings: An additional 1,701,375 shares held indirectly via a Revocable Trust, 12,177,521 shares via the L. Lee Stryker Trust, and 37,600 shares via the 1988 William D. Johnston Trust.
- Option origin: The option was granted on February 8, 2017, under the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the grant date.
- Remaining derivative position: Following the exercise, zero options from this grant remain beneficially owned, with an expiration date of February 7, 2027.
Ronda E. Stryker's November 2026 Option Exercise at Stryker Corp
According to the filing, Ronda E. Stryker, a director of Stryker Corp (NYSE:SYK), exercised a stock option on November 19, 2026, acquiring 3,605 shares of common stock at a price of $122.51 per share. The transaction was coded "M," indicating the exercise of an in-the-money or at-the-money derivative security. The form was signed by Austin Y. Ke as attorney-in-fact for Ronda E. Stryker and filed on November 20, 2026.
The filing discloses that following the transaction, Ronda E. Stryker directly holds 4,367 shares of Stryker Corp common stock. In addition to direct holdings, the filing reports three separate indirect beneficial ownership positions: 1,701,375 shares held by a Revocable Trust, 12,177,521 shares held by the L. Lee Stryker Trust, and 37,600 shares held by the 1988 William D. Johnston Trust.
The exercised option was originally granted on February 8, 2017, pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, and was described in the filing as "exercisable as to 20% on each of the first five anniversaries of the date of grant." The option carried an exercise price of $122.51 and an expiration date of February 7, 2027. The filing reports that zero options from this grant remain beneficially owned following the transaction.
What Was Disclosed
The Form 4 discloses a director-level stock option exercise at Stryker Corp, covering 3,605 shares at $122.51 on November 19, 2026, with resulting direct ownership of 4,367 shares and substantial indirect holdings reported across three trusts.




Please wait processing your request...